1. Home
  2. FSUN vs DMRA Comparison

FSUN vs DMRA Comparison

Compare FSUN & DMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FSUN

FirstSun Capital Bancorp

HOLD

Current Price

$40.16

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

DMRA

Damora Therapeutics Inc. Common Stock

N/A

Current Price

$29.00

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FSUN
DMRA
Founded
1892
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
FSUN
DMRA
Price
$40.16
$29.00
Analyst Decision
Buy
Buy
Analyst Count
3
2
Target Price
$45.00
$43.00
AVG Volume (30 Days)
238.1K
306.7K
Earning Date
04-27-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
29.00
121.48
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$79.34
N/A
Revenue Next Year
$14.67
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.95
$16.50
52 Week High
$42.34
$34.89

Technical Indicators

Market Signals
Indicator
FSUN
DMRA
Relative Strength Index (RSI) 59.30 46.05
Support Level $39.38 $28.16
Resistance Level $40.35 $34.23
Average True Range (ATR) 0.75 1.50
MACD -0.14 -0.25
Stochastic Oscillator 48.59 4.72

Price Performance

Historical Comparison
FSUN
DMRA

About FSUN FirstSun Capital Bancorp

Firstsun Capital Bancorp is the financial holding company. It provides a full range of deposit, lending, treasury management, wealth management, and online banking products and services. The company operates in two segments; Banking operations and mortgage operations, the majority of which are generated by the banking operations segment. The Banking segment originates loans and provides deposits and fee based services to consumer, business, and mortgage lending customers. Products offered include a full range of commercial and consumer banking and financial services. The Mortgage Operations segment originates, sells, services, and manages market risk from changes in interest rates on one-to-four family residential mortgage loans.

About DMRA Damora Therapeutics Inc. Common Stock

Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.

Share on Social Networks: